Several classification systems, all based on disease severity, have been created to guide treatment decisions in psoriasis. In the most widely used system, disease severity is scored according to ...

Even though he suffers from psoriasis, Joel Thomas considers himself a lucky man. Psoriasis is a chronic skin disorder that affects over seven and a half million Americans. Many are not as lucky ...

The overactive immune response in psoriasis can influence your brain’s chemicals, which can lead to both depression and ...

Tremfya is now approved for the treatment of plaque psoriasis, active psoriatic arthritis and ulcerative colitis.

Organon is set to acquire Roivant Sciences' Dermavant Sciences, known for developing immuno-dermatology treatments, including ...

RAPID CITY, S.D. (KOTA) - It causes puffy rashes, itchiness, and flaky scales and many people confuse it for either eczema or other topical rashes but plaque psoriasis is a different chronic condition ...

But here I am, a seventh grader with this monstrous plaque right in the middle ... the FDA approved any biologic agents. The best treatment for psoriasis at that time was known as Goeckerman ...

Patients should also be informed about the potential for developing chronic plaque-type psoriasis. Education about diagnosis and treatment of streptococcal infection with antibiotics should be ...

However, treatment options for this chronic immune-mediated disease ... patients aged 6 to 17 years with moderate to severe plaque psoriasis inadequately controlled by or intolerant to topical ...

The European Commission (EC) has licensed Celgene's Otezla (apremilast) for the treatment of moderate-to-severe chronic plaque psoriasis and alone or in combination with Disease Modifying ...

While there are a number of treatment options available ... scaly plaques on the surface of the skin. Psoriasis is considered ...